Researchers explore what happens when heart cells fail

July 29, 2014 by Jasmine Sola
Researchers explore what happens when heart cells fail
Left and right ventricles of a normal mouse heart (left) and one with a mutation in the cardiac isoform of myosin binding protein C.

Through a grant from the United States-Israel Binational Science Foundation, Biomedical Engineering Associate Professor Naomi Chesler will embark upon a new collaborative research project to better understand heart function and failure. "This is unique opportunity to combine theoretical and the experimental approaches and to develop a collaboration with an Israeli investigator," Chesler says.

Chesler will work with Richard Moss, the UW-Madison School of Medicine and Public Health associate dean for basic research, biotechnology and graduate studies; and with Amir Landesberg, dean of biomedical engineering at Technion-Israel Institute of Technology.

Landesberg has developed a novel model of at the cellular level, while Chesler's team has been improving methods to study heart function at the whole organ level in small animal models. Moss not only has expertise in experimental measurement of heart function at the , but also genetically engineered that have a mutation in one protein in the cells of the heart that generate force that leads to dilation and dysfunction.

These mice will allow Chesler and Moss to test the theoretical model developed by Landesberg.

While Moss will oversee the group that breeds the mice, Chesler will oversee experimental treatment of the mice.

Chesler also hopes to learn more about the mathematical model of heart cell function, which is Landesberg's expertise. Models, such as the one used by Landesberg, help bridge the gap in understanding functions in mice and functions in humans.

"We are hoping to understand what happens in people with heart disease. If we better understand heart cell function and dysfunction, we might be able to develop better metrics of early dysfunction," Chesler says. "If we find early dysfunction in people, then we might be able to treat them earlier and actually prevent heart failure."

Related Stories

Misplaced protein causes heart failure

March 6, 2014

Colchicine, a drug that's used to treat gout, has the beneficial side effect of lowering the risk of heart attack in patients taking it. Conversely, taxol, a drug for treating cancer, has the opposite effect; raising the ...

Healing the heart with fat

July 21, 2014

Too much dietary fat is bad for the heart, but the right kind of fat keeps the heart healthy, according to a paper published in The Journal of Experimental Medicine.

Recommended for you

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.